Hart and colleagues' meta-analysis in this issue reemphasizes the value of anticoagulation in patients with atrial fibrillation,
especially those at highest risk for stroke. These findings may lead to increased use of antithrombotic therapy in elderly
patients, who have the greatest risk for stroke but also are a group for whom the fear of bleeding complications with anticoagulation
is greatest.